bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells
Data up to Jan 2025
Total Citations Per Year
Abstract
References (44)
Apoptosis in the Pathogenesis and Treatment of Disease
1995 • 6,610 citations
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
1993 • 6,009 citations
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
1990 • 3,817 citations
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
1993 • 3,465 citations
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
1993 • 3,111 citations
p53 is required for radiation-induced apoptosis in mouse thymocytes
1993 • 2,911 citations
Bcl-2 and the regulation of programmed cell death
1994 • 2,346 citations
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
1992 • 1,877 citations
Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome Translocation
1984 • 1,761 citations
Cancer statistics, 1995
1995 • 1,434 citations
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
1991 • 1,223 citations
Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.
1992 • 1,063 citations
Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes.
1993 • 1,044 citations
Apoptotic cell death induced by c-myc is inhibited by bcl-2
1992 • 981 citations
High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
1993 • 738 citations
Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.
1993 • 597 citations
Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.
1995 • 537 citations
Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene
1993 • 495 citations
bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs.
1992 • 487 citations
Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity.
1994 • 333 citations
Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo.
1994 • 333 citations
Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation.
1995 • 311 citations
Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.
1993 • 275 citations
bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair.
1993 • 218 citations
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
1995 • 203 citations
Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation.
1993 • 201 citations
Paradoxical inhibition of solid tumor cell growth by bcl2.
1994 • 190 citations
Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy
1994 • 173 citations
BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells.
1995 • 144 citations
Expression of bcl-2 and the progression of human and rodent prostatic cancers.
1996 • 139 citations
Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide.
1995 • 137 citations
Development of apoptosis in irradiated murine tumors as a function of time and dose.
1993 • 117 citations
Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3.
1995 • 115 citations
Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells.
1995 • 87 citations
Development of Apoptosis in Irradiated Murine Tumors as a Function of Time and Dose
1993 • 80 citations
Combined Antitumor Effect of Suramin Plus Irradiation in Human Prostate Cancer Cells: The Role of Apoptosis
1993 • 49 citations
Radiation-induced Apoptosis: Its Role in a MADCaT (Mitosis-opoptosis-differentiation-calcium Toxicity) Scheme of Cytotoxicity Mechanisms
1992 • 48 citations
Radiation-induced apoptosis: effects of cell age and dose fractionation.
1995 • 47 citations
Induction of apoptosis in androgen‐independent human prostate cancer cells undergoing thymineless death
1994 • 38 citations
Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer
1994 • 35 citations
Bcl-2 protects murine erythroleukemia cells from p53-dependent and -independent radiation-induced cell death
1995 • 33 citations
Radiation-induced apoptosis of Ewing's sarcoma cells: DNA fragmentation and proteolysis of poly(ADP-ribose) polymerase.
1995 • 28 citations
Partial growth suppression of human prostate cancer cells by the Krev‐1 suppressor gene
1994 • 16 citations
Repair processes in the treatment and induction of cancer with radiation
1990 • 13 citations
Cited By (0)
No citing papers found in database